Addressing different biases in analysing drug use on cancer risk in diabetes in non-clinical trial settings-what, why and how?
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Addressing different biases in analysing drug use on cancer risk in diabetes in non-clinical trial settings-what, why and how?
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 14, Issue 7, Pages 579-585
Publisher
Wiley
Online
2011-12-16
DOI
10.1111/j.1463-1326.2011.01551.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin Peptides and Lung Cancer
- (2011) P. E. Gallagher et al. CURRENT CANCER DRUG TARGETS
- Role of the Renin-Angiotensin System in Gynecologic Cancers
- (2011) K. Ino et al. CURRENT CANCER DRUG TARGETS
- Role of the RAS in Pancreatic Cancer
- (2011) S. T. Lau et al. CURRENT CANCER DRUG TARGETS
- Comment: Analyses Using Time-Dependent Pioglitazone Usage in Cox Models May Lead to Wrong Conclusions About Its Association With Cancer
- (2011) Xilin Yang et al. DIABETES CARE
- Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
- (2011) A. Ferrara et al. DIABETES CARE
- Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
- (2011) J. D. Lewis et al. DIABETES CARE
- Angiotensin Receptor Blockade and Risk of Cancer in Type 2 Diabetes Mellitus: A Nationwide Case-Control Study
- (2011) Chia-Hsuin Chang et al. JOURNAL OF CLINICAL ONCOLOGY
- Are Large Sample Size Studies the Answer to Evaluate Effects of Drug Use in Non–Clinical Trial Settings?
- (2011) Xilin Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study
- (2010) Rose ZW Ting et al. Cardiovascular Diabetology
- Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
- (2010) X. Yang et al. DIABETES
- Use of sulphonylurea and cancer in type 2 diabetes—The Hong Kong Diabetes Registry
- (2010) Xilin Yang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Meta-analysis of trial data may support a causal role of hyperglycaemia in cancer
- (2010) X. L. Yang et al. DIABETOLOGIA
- Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
- (2010) J. A. Johnson et al. DIABETOLOGIA
- Linking diabetes and cancer: a consensus on complexity
- (2010) Andrew Renehan et al. LANCET
- Additive Interaction Between the Renin-Angiotensin System and Lipid Metabolism for Cancer in Type 2 Diabetes
- (2009) X. Yang et al. DIABETES
- Low LDL Cholesterol, Albuminuria, and Statins for the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
- (2009) X. Yang et al. DIABETES CARE
- Does diabetes therapy influence the risk of cancer?
- (2009) U. Smith et al. DIABETOLOGIA
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
- (2009) L. G. Hemkens et al. DIABETOLOGIA
- Bias: Considerations for research practice
- (2008) T. Gerhard AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus
- (2008) X. Yang et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes
- (2008) X. Yang et al. ENDOCRINE-RELATED CANCER
- Immortal Time Bias in Pharmacoepidemiology
- (2007) S. Suissa AMERICAN JOURNAL OF EPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started